| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2022―Oct―03 |
Impact of COVID-19 on the Prescribing Pattern of Oral Anticoagulants for Atrial Fibrillation After Cardiac Surgery |
Dannick Brochu, Amélie St-Arnaud, Louis-Étienne Marchand, Pierre Voisine, Julie Méthot |
| 2 |
[GO] |
2022―Jan―10 |
QT Prolongation in Critically Ill Patients With SARS-CoV-2 Infection |
Wasim S. El Nekidy, Khalid Almuti, Hazem ElRefaei, Bassam Atallah, Lana M. Mohammad, Wael AlMahmeed, et al. (+4) Mohamed Badr, Khaled Abdallah, Fadi Hamed, Jihad Mallat |
| 3 |
[GO] |
2021―May―09 |
COVID-19 and Acute Myocardial Injury and Infarction: Related Mechanisms and Emerging Challenges |
Antonis S. Manolis, Antonis A. Manolis, Theodora A. Manolis, Helen Melita |
| 4 |
[GO] |
2021―Mar―11 |
COVID-19: The Heart of the Matter-Pathological Changes and a Proposed Mechanism |
Sharon E. Fox, Richard S. Vander Heide |
| 5 |
[GO] |
2020―Dec―17 |
Therapeutic Implications of COVID-19 for the Interventional Cardiologist |
Matthew Kelham, Fizzah A. Choudry, Stephen Hamshere, Anne-Marie Beirne, Krishnaraj S. Rathod, Andreas Baumbach, et al. (+3) Amrita Ahluwalia, Anthony Mathur, Daniel A. Jones |
| 6 |
[GO] |
2020―Nov―24 |
Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Blockers With Severity of COVID-19: A Multicenter, Prospective Study |
Hakeam A. Hakeam, Muhannad Alsemari, Zainab Al Duhailib, Leen Ghonem, Saad A. Alharbi, Eid Almutairy, et al. (+6) Nader M. Bin Sheraim, Meshal Alsalhi, Ali Alhijji, Sara AlQahtani, Mohammed Khalid, Mazin Barry |
| 7 |
[GO] |
2020―Oct―20 |
Hypothesis: Sex-Related Differences in ACE2 Activity May Contribute to Higher Mortality in Men Versus Women With COVID-19 |
Husam M. Salah, Jawahar L. Mehta |
| 8 |
[GO] |
2020―Sep―14 |
COVID-19 Infection: Viral Macro- and Micro-Vascular Coagulopathy and Thromboembolism/Prophylactic and Therapeutic Management |
Antonis S. Manolis, Theodora A. Manolis, Antonis A. Manolis, Despoina Papatheou, Helen Melita |
| 9 |
[GO] |
2020―Aug―04 |
Renin-Angiotensin System Blockade and Mortality in Patients With Hypertension and COVID-19 Infection |
Husam M. Salah, Guisseppe Calcaterra, Jawahar L. Mehta |
| 10 |
[GO] |
2020―Jul―23 |
Hydroxychloroquine in COVID-19 Therapy: Protection Versus Proarrhythmia |
Christopher Stremmel, Antonia Kellnar, Steffen Massberg, Stefan Kääb |
| 11 |
[GO] |
2020―Jul―03 |
Incretin-Based Therapies Role in COVID-19 Era: Evolving Insights |
Anca Pantea Stoian, Nikolaos Papanas, Martin Prazny, Ali A. Rizvi, Manfredi Rizzo |
| 12 |
[GO] |
2020―Apr―30 |
Evidence for Use or Disuse of Renin-Angiotensin System Modulators in Patients Having COVID-19 With an Underlying Cardiorenal Disorder |
Himanshu Sankrityayan, Ajinath Kale, Nisha Sharma, Hans-Joachim Anders, Anil Bhanudas Gaikwad |
